Evidence map›Paper›PMID 40000749›Full record

ArticleNature2025

Author Correction: A comprehensive spatio-cellular map of the human hypothalamus.

John A Tadross, Lukas Steuernagel, Georgina K C Dowsett, Katherine A Kentistou, Sofia Lundh, Marta Porniece, Paul Klemm, Kara Rainbow, Henning Hvid, Katarzyna Kania and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The evolving landscape of obesity pharmacotherapy.Nature reviews. Drug discovery · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

John A Tadross *Medical Research Council Metabolic Diseases Unit, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-8424-1252
Lukas Steuernagel *Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany.ORCID http://orcid.org/0000-0003-0043-1436
Georgina K C Dowsett *Medical Research Council Metabolic Diseases Unit, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
Katherine A KentistouMedical Research Council Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-5816-664X
Sofia LundhResearch & Early Development, Novo Nordisk A/S, Måløv, Denmark.ORCID http://orcid.org/0000-0002-4552-0312
Marta PornieceDepartment of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany.ORCID http://orcid.org/0000-0003-2330-5846
Paul KlemmDepartment of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany.ORCID http://orcid.org/0000-0002-5985-1737
Kara RainbowMedical Research Council Metabolic Diseases Unit, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
Henning HvidResearch & Early Development, Novo Nordisk A/S, Måløv, Denmark.
Katarzyna KaniaGenomics Core, Cancer Research UK Cambridge Institute, Cambridge, UK.
Joseph Polex-WolfResearch & Early Development, Novo Nordisk A/S, Måløv, Denmark.ORCID http://orcid.org/0000-0002-0441-8872
Lotte Bjerre KnudsenResearch & Early Development, Novo Nordisk A/S, Måløv, Denmark.ORCID http://orcid.org/0000-0002-2439-7116
Charles PykeResearch & Early Development, Novo Nordisk A/S, Måløv, Denmark.
John R B PerryMedical Research Council Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6483-3771
Brian Y H LamMedical Research Council Metabolic Diseases Unit, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-3638-9025
Jens C Brüning *Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany. bruening@sf.mpg.de.ORCID http://orcid.org/0000-0002-6619-0092
Giles S H Yeo *Medical Research Council Metabolic Diseases Unit, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK. gshy2@cam.ac.uk.ORCID http://orcid.org/0000-0001-8823-3615

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40000749
PMCPMC11903310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.